Envestnet Asset Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $214M | Sell |
1,122,659
-104,009
| -8% | -$17.9M | 0.05% | 340 |
|
|
2026
Q1 | $207M | Buy |
1,226,668
+3,618
| +0.3% | +$619K | 0.06% | 321 |
|
|
2025
Q4 | $206M | Buy |
1,223,050
+1,172,666
| +2,327% | +$190M | 0.06% | 293 |
|
|
2025
Q3 | $7.27M | Sell |
50,384
-5,695
| -10% | -$777K | ﹤0.01% | 1976 |
|
|
2025
Q2 | $7.09M | Buy |
56,079
+3,051
| +6% | +$375K | ﹤0.01% | 1966 |
|
|
2025
Q1 | $6.78M | Sell |
53,028
-3,941
| -7% | -$534K | ﹤0.01% | 1917 |
|
|
2024
Q4 | $7.53M | Buy |
56,969
+1,138
| +2% | +$160K | ﹤0.01% | 1830 |
|
|
2024
Q3 | $8.13M | Sell |
55,831
-6,827
| -11% | -$988K | ﹤0.01% | 1782 |
|
|
2024
Q2 | $8.6M | Sell |
62,658
-4,135
| -6% | -$552K | ﹤0.01% | 1655 |
|
|
2024
Q1 | $9.17M | Buy |
66,793
+9,067
| +16% | +$1.24M | ﹤0.01% | 1580 |
|
|
2023
Q4 | $7.84M | Sell |
57,726
-13,231
| -19% | -$1.61M | ﹤0.01% | 1591 |
|
|
2023
Q3 | $8.68M | Sell |
70,957
-18,407
| -21% | -$2.34M | ﹤0.01% | 1466 |
|
|
2023
Q2 | $11.3M | Sell |
89,364
-4,697
| -5% | -$610K | 0.01% | 1223 |
|
|
2023
Q1 | $12.1M | Sell |
94,061
-101,304
| -52% | -$13.3M | 0.01% | 1135 |
|
|
2022
Q4 | $25.6M | Buy |
195,365
+35,253
| +22% | +$4.56M | 0.01% | 730 |
|
|
2022
Q3 | $18.7M | Buy |
160,112
+35,655
| +29% | +$4.43M | 0.01% | 812 |
|
|
2022
Q2 | $14.6M | Sell |
124,457
-14,449
| -10% | -$1.72M | 0.01% | 955 |
|
|
2022
Q1 | $18.1M | Sell |
138,906
-17,504
| -11% | -$2.28M | 0.01% | 891 |
|
|
2021
Q4 | $23.9M | Buy |
156,410
+8,915
| +6% | +$1.38M | 0.01% | 765 |
|
|
2021
Q3 | $23.8M | Sell |
147,495
-5,887
| -4% | -$991K | 0.01% | 721 |
|
|
2021
Q2 | $25.1M | Sell |
153,382
-27,468
| -15% | -$4.23M | 0.01% | 693 |
|
|
2021
Q1 | $27.2M | Sell |
180,850
-102,414
| -36% | -$16.3M | 0.02% | 606 |
|
|
2020
Q4 | $42.9M | Sell |
283,264
-151,813
| -35% | -$21.7M | 0.03% | 389 |
|
|
2020
Q3 | $58.9M | Buy |
435,077
+14,393
| +3% | +$1.95M | 0.05% | 275 |
|
|
2020
Q2 | $57.5M | Buy |
420,684
+328,599
| +357% | +$41.9M | 0.06% | 257 |
|
|
2020
Q1 | $9.92M | Buy |
92,085
+11,882
| +15% | +$1.37M | 0.01% | 685 |
|
|
2019
Q4 | $9.66M | Buy |
80,203
+1,755
| +2% | +$196K | 0.01% | 820 |
|
|
2019
Q3 | $7.81M | Sell |
78,448
-13,182
| -14% | -$1.38M | 0.01% | 867 |
|
|
2019
Q2 | $10M | Sell |
91,630
-3,304
| -3% | -$351K | 0.01% | 732 |
|
|
2019
Q1 | $10.6M | Buy |
94,934
+23,011
| +32% | +$2.52M | 0.01% | 667 |
|
|
2018
Q4 | $6.94M | Buy |
71,923
+53,935
| +300% | +$5.72M | 0.01% | 755 |
|
|
2018
Q3 | $2.19M | Sell |
17,988
-7,601
| -30% | -$895K | ﹤0.01% | 593 |
|
|
2018
Q2 | $2.81M | Buy |
25,589
+7
| +0% | +$749 | 0.01% | 695 |
|
|
2018
Q1 | $2.67M | Sell |
25,582
-4,305
| -14% | -$477K | 0.01% | 607 |
|
|
2017
Q4 | $3.19M | Sell |
29,887
-121,184
| -80% | -$13M | 0.01% | 766 |
|
|
2017
Q3 | $16.8M | Buy |
151,071
+26,691
| +21% | +$2.85M | 0.04% | 262 |
|
|
2017
Q2 | $12.9M | Buy |
124,380
+20,751
| +20% | +$2.04M | 0.04% | 312 |
|
|
2017
Q1 | $10.1M | Buy |
103,629
+38,319
| +59% | +$3.67M | 0.03% | 360 |
|
|
2016
Q4 | $5.78M | Buy |
65,310
+19,557
| +43% | +$1.78M | 0.02% | 493 |
|
|
2016
Q3 | $4.41M | Buy |
45,753
+4,488
| +11% | +$427K | 0.02% | 632 |
|
|
2016
Q2 | $3.54M | Buy |
41,265
+4,680
| +13% | +$420K | 0.01% | 778 |
|
|
2016
Q1 | $3.18M | Sell |
36,585
-66,957
| -65% | -$5.99M | 0.01% | 759 |
|
|
2015
Q4 | $11.7M | Sell |
103,542
-154,515
| -60% | -$16.8M | 0.05% | 303 |
|
|
2015
Q3 | $26.1M | Sell |
258,057
-66,093
| -20% | -$7.93M | 0.13% | 137 |
|
|
2015
Q2 | $39.9M | Buy |
324,150
+45,939
| +17% | +$5.5M | 0.19% | 108 |
|
|
2015
Q1 | $31.8M | Buy |
278,211
+148,062
| +114% | +$16.3M | 0.16% | 133 |
|
|
2014
Q4 | $13.2M | Sell |
130,149
-22,707
| -15% | -$2.21M | 0.13% | 124 |
|
|
2014
Q3 | $13.9M | Buy |
152,856
+45,333
| +42% | +$3.98M | 0.14% | 137 |
|
|
2014
Q2 | $9.21M | Buy |
107,523
+93,603
| +672% | +$7.37M | 0.1% | 166 |
|
|
2014
Q1 | $1.1M | Buy |
13,920
+6,222
| +81% | +$518K | 0.01% | 436 |
|
|
2013
Q4 | $583K | Sell |
7,698
-12,039
| -61% | -$854K | 0.01% | 587 |
|
|
2013
Q3 | $1.38M | Buy |
19,737
+11,349
| +135% | +$744K | 0.02% | 343 |
|
|
2013
Q2 | $486K | Buy |
+8,388
| New | +$485K | 0.01% | 581 |
|
Other funds holding IBB
CB
Envestnet Asset Management's IBB Position: Q2 2026 in Review
Envestnet Asset Management reduced its iShares Biotechnology ETF (IBB) stake by 8.5% in Q2 2026, selling an estimated $17.9M and leaving 1,122,659 shares worth $214M. The position accounts for 0.05% of the portfolio, ranked #340.
Envestnet Asset Management first reported a position in IBB in Q2 2013 and has held it in 53 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Envestnet Asset Management held 1,122,659 shares of iShares Biotechnology ETF worth $214M as of Q2 2026.
- Envestnet Asset Management sold 104,009 iShares Biotechnology ETF shares in Q2 2026, an estimated $17.9M.
- iShares Biotechnology ETF made up 0.05% of Envestnet Asset Management's portfolio in Q2 2026, its #340 holding.
- Envestnet Asset Management first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 53 quarters since.
- 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.